Meanwhile, ASGR1 + EV levels increased with disease severity, at almost twofold in pre-cirrhotic NASH and threefold in cirrhotic patients, compared to healthy controls. This evidence concerns the gene ASGR1 and metabolic dysfunction-associated steatohepatitis.